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8, 2009.Submitted May 12, 2010; accepted May 13, 2010.COMMENTARYThomas L. Forbes, MD, London, Ontario, Canada
Dr Schneider and Prof Naylor have offered a spirited debate
regarding the optimal approach to patients with significant asymp-
tomatic carotid artery stenoses. Their arguments are clear, reasoned,
passionate, and in direct opposition with each other. Both would
agree that stroke in patients with asymptomatic stenoses is a relatively
rare event, and, given its potentially devastating consequences, should
be avoided. Further points of agreement are few and far between.
Most issues of contention are a result of differing interpretations of
the same data or studies. For example, Prof Naylor’s claim that stroke risk
is declining with medical therapy is supported by several studies with
which Dr Schneider has issue given their inclusion of patients with lesser
degrees of stenosis who would not have been surgical candidates in the
firstplace.ProfNaylorcounterswith theargument that strokeriskhasnot
been consistently shown to be directly related to degree of stenosisIn any event, strategies consisting of medical therapy alone
or combined with surgical intervention have both proven highly
successful at preventing stroke in asymptomatic patients. Innu-
merable studies offer support, and few would argue with this.
Where controversy remains, and will probably always persist,
is in which instances should one strategy be chosen over an-
other? Our debaters both recommend another study to help to
answer these questions, but I suspect that such a study’s data
would continue to be interpreted differently depending on what
side of the argument one sits. This likely will remain a polarizing
issue.
So, although convincing, Dr Schneider and Prof Naylor have
probably not succeeded in persuading each other to change their
approaches, but have certainly gone a long way in educating the
rest of us.
